First Foundation Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $853K | Buy |
2,105
+648
| +44% | +$263K | 0.03% | 200 |
|
2025
Q1 | $725K | Buy |
1,457
+914
| +168% | +$455K | 0.03% | 193 |
|
2024
Q4 | $282K | Buy |
543
+3
| +0.6% | +$1.56K | 0.01% | 294 |
|
2024
Q3 | $334K | Sell |
540
-193
| -26% | -$119K | 0.01% | 270 |
|
2024
Q2 | $405K | Sell |
733
-85
| -10% | -$47K | 0.02% | 246 |
|
2024
Q1 | $475K | Sell |
818
-62
| -7% | -$36K | 0.02% | 232 |
|
2023
Q4 | $467K | Sell |
880
-1,225
| -58% | -$650K | 0.02% | 238 |
|
2023
Q3 | $1.07M | Buy |
2,105
+128
| +6% | +$64.8K | 0.05% | 174 |
|
2023
Q2 | $1.03M | Buy |
1,977
+126
| +7% | +$65.7K | 0.04% | 174 |
|
2023
Q1 | $1.07M | Buy |
1,851
+196
| +12% | +$113K | 0.05% | 173 |
|
2022
Q4 | $911K | Buy |
1,655
+33
| +2% | +$18.2K | 0.04% | 189 |
|
2022
Q3 | $823K | Sell |
1,622
-59
| -4% | -$29.9K | 0.04% | 185 |
|
2022
Q2 | $913K | Buy |
1,681
+107
| +7% | +$58.1K | 0.04% | 182 |
|
2022
Q1 | $930K | Buy |
1,574
+353
| +29% | +$209K | 0.03% | 194 |
|
2021
Q4 | $815K | Buy |
1,221
+56
| +5% | +$37.4K | 0.03% | 219 |
|
2021
Q3 | $666K | Buy |
1,165
+286
| +33% | +$163K | 0.02% | 240 |
|
2021
Q2 | $443K | Sell |
879
-249
| -22% | -$125K | 0.02% | 301 |
|
2021
Q1 | $515K | Sell |
1,128
-875
| -44% | -$399K | 0.02% | 261 |
|
2020
Q4 | $933K | Buy |
2,003
+84
| +4% | +$39.1K | 0.04% | 196 |
|
2020
Q3 | $847K | Sell |
1,919
-120
| -6% | -$53K | 0.04% | 192 |
|
2020
Q2 | $739K | Sell |
2,039
-565
| -22% | -$205K | 0.04% | 196 |
|
2020
Q1 | $738K | Buy |
2,604
+1,606
| +161% | +$455K | 0.05% | 189 |
|
2019
Q4 | $324K | Buy |
998
+79
| +9% | +$25.6K | 0.02% | 285 |
|
2019
Q3 | $268K | Sell |
919
-3
| -0.3% | -$875 | 0.01% | 302 |
|
2019
Q2 | $271K | Sell |
922
-59
| -6% | -$17.3K | 0.02% | 290 |
|
2019
Q1 | $269K | Buy |
+981
| New | +$269K | 0.02% | 284 |
|